Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion

OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT2) inhibition causes an increase in endogenous glucose production (EGP). However, the mechanisms are unclear. We studied the effect of SGLT2 inhibitors on EGP in subjects with type 2 diabetes (T2D) and without diabetes (non-DM) in kidney transplant reci...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Diabetes Care
Main Authors: Solis-Herrera, Carolina, Daniele, Giuseppe, Alatrach, Mariam, Agyin, Christina, Triplitt, Curtis, Adams, John, Patel, Rupal, Gastaldelli, Amalia, Honka, Henri, Chen, Xi, Abdul-Ghani, Muhammad, Cersosimo, Eugenio, Del Prato, Stephano, DeFronzo, Ralph
פורמט: Artigo
שפה:Inglês
יצא לאור: American Diabetes Association 2020
נושאים:
Emerging Therapies: Drugs and Regimens
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171949/
https://ncbi.nlm.nih.gov/pubmed/32144165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-2177
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים